EKSO vs AARD โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
AARD Captures Institutional Edge (2โ1 Pillars ยท 4โ4 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Aardvark Therapeutics, Inc. Common Stock (AARD) driven by superior Growth & Margin, Options & Structure while EKSO counters with relative strength in Momentum & Technical. Fundamentally, EKSO trades at N/M Forward P/E with -119.7% operating margin (-38.3% YoY revenue) versus AARD at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, EKSO sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against AARD sits in UNCLASSIFIED (26th %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | EKSO | AARD | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $42.0M | $21.9M | Larger Scale | EKSO |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | -38.3% | +0.0% | Higher Growth | AARD |
| Operating Margin (TTM) Profitability | -119.7% | 0.0% | Higher Margin | AARD |
| Net Profit Margin Profitability | -91.4% | 0.0% | Higher Margin | AARD |
| Return on Equity (ROE) Capital Efficiency | -107.6% | -66.0% | Higher ROE | AARD |
| 52-Week Range Position Momentum | 87% ($0โ$14) | 0% ($1โ$17) | Stronger Trend | EKSO |
| Beta / 30D Volatility Risk Regime | 2.16ฮฒ ยท 76% Vol | 3.84ฮฒ ยท 284% Vol | Lower Realized Risk | EKSO |
| Unified Institutional Score Composite Signal | 58.1 / 100 (HOLD) | 45.9 / 100 (HOLD) | Higher Composite | EKSO |